1-4 of 4
Peter Cooper
Close
Sort by
Journal Articles

Impact of Oral Arginine Therapy on Global Arginine Bioavailability in Nigerian Children with Sickle Cell Anemia and Vaso-Occlusive Pain

Richard Onalo, MBBS, Peter Cooper, MBBS, Barend C. Vorster, MD, Marli Dercksen, PhD, Antoinette Cilliers, MBBS, Uche Nnebe-Agumadu, MBBS, Claudia R. Morris, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-134123
Published: 2020
Journal Articles

Oral Arginine Therapy As a Novel Adjuvant in the Management of Acute Pain in Children with Sickle Cell Anemia in Nigeria: A Randomized Placebo-Controlled Trial

Richard Onalo, FCPaed, Peter Cooper, FCPaed, Antoinette Cilliers, FCPaed, Uche Nnebe-Agumadu, FCPaed, Oluseyi Oniyangi, FCPaed, Damilare Oladimeji, MSc Statistics, Claudia R. Morris, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 613.
https://doi.org/10.1182/blood-2019-122510
Published: 2019
Journal Articles

A Novel Protac®-Modified Thrombin Generation Assay To Identify Individuals at Higher Thrombotic Risk.

Alex Gatt, MD, Joost van Veen, MD, Peter Cooper, Steve Kitchen, PhD, Michael Makris, MD
Journal: Blood
Blood (2006) 108 (11): 1472.
https://doi.org/10.1182/blood.V108.11.1472.1472
Published: 2006
Journal Articles

Reversal of Anticoagulation as Assessed by Thrombin Generation Measurement.

Alex Gatt, MD, Joost van Veen, MD, Peter Cooper, Steve Kitchen, PhD, Michael Makris, MD
Journal: Blood
Blood (2006) 108 (11): 876.
https://doi.org/10.1182/blood.V108.11.876.876
Published: 2006